Information provided by St. Baldrick's Foundation:
The St. Baldrick’s Foundation, a volunteer-driven charity dedicated to raising money for childhood cancer research, is proud to grant a $130,404 St. Baldrick’s Fellow award for a period of two years to Chandrika Gowda, M.D., a pediatric oncologist at Penn State Milton S. Hershey Medical Center.
Dr. Gowda’s research project studies the regulation of the function of the Ikaros protein. The loss of function of the Ikaros protein is associated with the development of high-risk acute lymphoblastic leukemia (ALL). Dr. Gowda is studying the way that Ikaros activity prevents development of leukemia.
“We are trying to understand the mechanism of certain leukemias which are difficult to treat with conventional chemotherapy,” Gowda says. “Funding from the St. Baldrick’s Foundation helps us study the role of Ikaros as a suppressor of leukemia, opening doors to the development of new targeted chemotherapeutic agents.”
Worldwide a child is diagnosed with cancer every three minutes, and one in five children diagnosed in the U.S. will not survive, making the Foundation’s efforts to conquer childhood cancers critical. Through the vigorous efforts of volunteers and supporters in the U.S. and around the world, the Foundation is not only honored to award this local grant but will grant a total of more than $23 million in its 2012 summer grant cycle.
To locate or organize an event in your community, sign-up to shave, donate or volunteer, visit www.StBaldricks.org. You can also become a fan on Facebook, follow us on Twitter and visit the Foundation’s YouTube and Vimeo channels.
The St. Baldrick’s Foundation, a volunteer-driven charity dedicated to raising money for childhood cancer research, is proud to grant a $130,404 St. Baldrick’s Fellow award for a period of two years to Chandrika Gowda, M.D., a pediatric oncologist at Penn State Milton S. Hershey Medical Center.
Dr. Gowda’s research project studies the regulation of the function of the Ikaros protein. The loss of function of the Ikaros protein is associated with the development of high-risk acute lymphoblastic leukemia (ALL). Dr. Gowda is studying the way that Ikaros activity prevents development of leukemia.
“We are trying to understand the mechanism of certain leukemias which are difficult to treat with conventional chemotherapy,” Gowda says. “Funding from the St. Baldrick’s Foundation helps us study the role of Ikaros as a suppressor of leukemia, opening doors to the development of new targeted chemotherapeutic agents.”
Worldwide a child is diagnosed with cancer every three minutes, and one in five children diagnosed in the U.S. will not survive, making the Foundation’s efforts to conquer childhood cancers critical. Through the vigorous efforts of volunteers and supporters in the U.S. and around the world, the Foundation is not only honored to award this local grant but will grant a total of more than $23 million in its 2012 summer grant cycle.
To locate or organize an event in your community, sign-up to shave, donate or volunteer, visit www.StBaldricks.org. You can also become a fan on Facebook, follow us on Twitter and visit the Foundation’s YouTube and Vimeo channels.